• 1
    Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006; 56: 106130.
  • 2
    Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of Surveillance, Epidemiology and End Results program data. J Urol. 2002; 167: 5760.
  • 3
    Lam JS, Belldegrun AS, Pantuck AJ. Long-term outcomes of the surgical management of renal cell carcinoma. World J Urol. 2006; 24: 255266.
  • 4
    Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol. 2002; 168: 23952400.
  • 5
    Esho JO. Radical surgery for renal cell carcinoma. Eur Urol. 1978; 4: 338341.
  • 6
    Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969; 101: 297301.
  • 7
    Thompson RH, Cheville JC, Lohse CM, et al. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer. 2005; 104: 5360.
  • 8
    Hayakawa M, Nakajima F, Higa I, Koyama Y, Hatano T, Osawa A. [Study on clinical courses of 7 patients undergone resection of adjacent organs in the treatment of locally extensive renal cell carcinoma]. Nippon Hinyokika Gakkai Zasshi. 1995; 86: 13021305.
  • 9
    Fukuda M, Satomi Y, Nakahashi M, et al. [Treatment and prognosis of T 4 renal cell carcinoma]. Nippon Hinyokika Gakkai Zasshi. 1999; 90: 753762.
  • 10
    Skinner DG, Vermillion CD, Colvin RB. The surgical management of renal cell carcinoma. J Urol. 1972; 107: 705710.
  • 11
    Jacobsohn KM, Wood CG. Adjuvant therapy for renal cell carcinoma. Semin Oncol. 2006; 33: 576582.
  • 12
    Bellmunt J, Montagut C, Albiol S, Carles J, Maroto P, Orsola A. Present strategies in the treatment of metastatic renal cell carcinoma: an update on molecular targeting agents. BJU Int. 2007; 99: 274280.
  • 13
    Svatek RS, Lotan Y, Hermann M, Duchene DA, Sagalowsky AI, Cadeddu JA. The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma. J Urol. 2006; 176(4 Pt 1): 13211325; discussion 125.
  • 14
    Greene FL. American Joint Committee on Cancer. American Cancer Society. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002.
  • 15
    Eble JN, World Health Organization. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; Oxford: Oxford University Press distributor, 2004.
  • 16
    Nativ O, Sabo E, Reiss A, Wald M, Madjar S, Moskovitz B. Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma. Urology. 1998; 51: 693696.
  • 17
    Bechtold RE, Dyer RB, Zagoria RJ, Chen MY. The perirenal space: relationship of pathologic processes to normal retroperitoneal anatomy. Radiographics. 1996; 16: 841854.
  • 18
    Connolly J, Eisner D, Goldman S, Stutzman R, Steiner M. Benign retroperitoneal fibrosis and renal cell carcinoma. J Urol. 1993; 149: 15351537.
  • 19
    Levy DA, Slaton JW, Swanson DA, Dinney CP. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol. 1998; 159: 11631167.
  • 20
    Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004; 94: 3341.